Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.72M | 11.17M | 10.59M | 11.62M | 12.64M |
| Total Depreciation and Amortization | 2.46M | 2.34M | 2.22M | 2.37M | 2.51M |
| Total Amortization of Deferred Charges | 514.40K | 514.40K | 514.40K | 284.90K | 56.20K |
| Total Other Non-Cash Items | 1.28M | 1.67M | 2.08M | 686.10K | -697.50K |
| Change in Net Operating Assets | -6.87M | -6.87M | -6.87M | -2.85M | 1.16M |
| Cash from Operations | 9.10M | 8.83M | 8.54M | 12.11M | 15.67M |
| Capital Expenditure | -4.88M | -4.88M | -4.88M | -6.26M | -7.64M |
| Sale of Property, Plant, and Equipment | 17.80K | 17.80K | 17.80K | 8.90K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00M | -8.85M | -16.70M | -10.42M | -4.15M |
| Cash from Investing | -5.87M | -13.71M | -21.56M | -16.67M | -11.79M |
| Total Debt Issued | 75.54M | 75.54M | 75.54M | 62.31M | 49.09M |
| Total Debt Repaid | -21.73M | -21.73M | -21.73M | -20.18M | -18.63M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -24.83M | -24.83M | -24.83M | -15.00M | -5.17M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -55.58M | -28.39M | -1.19M | 11.36M | 23.90M |
| Cash from Financing | -3.41M | 68.00K | 3.56M | 4.92M | 6.29M |
| Foreign Exchange rate Adjustments | 2.29M | 1.75M | 1.21M | -766.20K | -2.74M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.12M | -3.06M | -8.26M | -403.00K | 7.43M |